Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Cocaine uptake is decreased in the brain of detoxified cocaine abusers.

Volkow ND, Wang GJ, Fowler JS, Logan J, Hitzemannn R, Gatley SJ, MacGregor RR, Wolf AP.

Neuropsychopharmacology. 1996 Mar;14(3):159-68.

2.

Effects of chronic cocaine abuse on postsynaptic dopamine receptors.

Volkow ND, Fowler JS, Wolf AP, Schlyer D, Shiue CY, Alpert R, Dewey SL, Logan J, Bendriem B, Christman D, et al.

Am J Psychiatry. 1990 Jun;147(6):719-24.

PMID:
2343913
3.

Striatal dopamine D2 receptor availability predicts the thalamic and medial prefrontal responses to reward in cocaine abusers three years later.

Asensio S, Romero MJ, Romero FJ, Wong C, Alia-Klein N, Tomasi D, Wang GJ, Telang F, Volkow ND, Goldstein RZ.

Synapse. 2010 May;64(5):397-402. doi: 10.1002/syn.20741.

4.

Sustained withdrawal allows normalization of in vivo [11C]N-methylspiperone dopamine D2 receptor binding after chronic binge cocaine: a positron emission tomography study in rats.

Maggos CE, Tsukada H, Kakiuchi T, Nishiyama S, Myers JE, Kreuter J, Schlussman SD, Unterwald EM, Ho A, Kreek MJ.

Neuropsychopharmacology. 1998 Aug;19(2):146-53.

5.

A new PET ligand for the dopamine transporter: studies in the human brain.

Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, Gatley SJ, Schlyer DJ, Pappas N.

J Nucl Med. 1995 Dec;36(12):2162-8.

6.

Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior.

Martinez D, Broft A, Foltin RW, Slifstein M, Hwang DR, Huang Y, Perez A, Frankle WG, Cooper T, Kleber HD, Fischman MW, Laruelle M.

Neuropsychopharmacology. 2004 Jun;29(6):1190-202. Erratum in: Neuropsychopharmacology. 2004 Sep;29(9):1763. Frankel, W Gordon [corrected to Frankle, W Gordon].

7.

Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers.

Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ, Dewey SL, Wolf AP.

Synapse. 1993 Jun;14(2):169-77.

PMID:
8101394
8.

Comparable changes in synaptic dopamine induced by methylphenidate and by cocaine in the baboon brain.

Volkow ND, Fowler JS, Gatley SJ, Dewey SL, Wang GJ, Logan J, Ding YS, Franceschi D, Gifford A, Morgan A, Pappas N, King P.

Synapse. 1999 Jan;31(1):59-66.

PMID:
10025684
9.

Decreased dopamine transporters with age in health human subjects.

Volkow ND, Fowler JS, Wang GJ, Logan J, Schlyer D, MacGregor R, Hitzemann R, Wolf AP.

Ann Neurol. 1994 Aug;36(2):237-9.

PMID:
8053661
10.

PET study of competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects.

Schlaepfer TE, Pearlson GD, Wong DF, Marenco S, Dannals RF.

Am J Psychiatry. 1997 Sep;154(9):1209-13.

PMID:
9286178
11.

[11C]beta-CIT-FE, a radioligand for quantitation of the dopamine transporter in the living brain using positron emission tomography.

Halldin C, Farde L, Lundkvist C, Ginovart N, Nakashima Y, Karlsson P, Swahn CG.

Synapse. 1996 Apr;22(4):386-90.

PMID:
8867033
12.

Stimulant-induced dopamine increases are markedly blunted in active cocaine abusers.

Volkow ND, Tomasi D, Wang GJ, Logan J, Alexoff DL, Jayne M, Fowler JS, Wong C, Yin P, Du C.

Mol Psychiatry. 2014 Sep;19(9):1037-43. doi: 10.1038/mp.2014.58. Epub 2014 Jun 10.

13.

Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain.

Tsukada H, Nishiyama S, Kakiuchi T, Ohba H, Sato K, Harada N, Nakanishi S.

Brain Res. 1999 Dec 4;849(1-2):85-96.

PMID:
10592290
14.

Distribution of tracer levels of cocaine in the human brain as assessed with averaged [11C]cocaine images.

Telang FW, Volkow ND, Levy A, Logan J, Fowler JS, Felder C, Wong C, Wang GJ.

Synapse. 1999 Mar 15;31(4):290-6.

PMID:
10051110
15.

Imaging endogenous dopamine competition with [11C]raclopride in the human brain.

Volkow ND, Wang GJ, Fowler JS, Logan J, Schlyer D, Hitzemann R, Lieberman J, Angrist B, Pappas N, MacGregor R, et al.

Synapse. 1994 Apr;16(4):255-62.

PMID:
8059335
16.

PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter.

Helfenbein J, Sandell J, Halldin C, Chalon S, Emond P, Okubo Y, Chou YH, Frangin Y, Douziech L, Gareau L, Swahn CG, Besnard JC, Farde L, Guilloteau D.

Nucl Med Biol. 1999 Jul;26(5):491-9.

PMID:
10473187
17.

Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain.

Volkow ND, Wang GJ, Fowler JS, Fischman M, Foltin R, Abumrad NN, Gatley SJ, Logan J, Wong C, Gifford A, Ding YS, Hitzemann R, Pappas N.

Life Sci. 1999;65(1):PL7-12.

PMID:
10403500
18.

Carbon-11-cocaine binding compared at subpharmacological and pharmacological doses: a PET study.

Volkow ND, Fowler JS, Logan J, Gatley SJ, Dewey SL, MacGregor RR, Schlyer DJ, Pappas N, King P, wang GJ, et al.

J Nucl Med. 1995 Jul;36(7):1289-97.

19.

Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex.

Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, Logan J, Franceschi D, Gatley J, Hitzemann R, Gifford A, Wong C, Pappas N.

Am J Psychiatry. 2001 Dec;158(12):2015-21.

PMID:
11729018
20.

Effects of binge pattern cocaine administration on dopamine D1 and D2 receptors in the rat brain: an in vivo study using positron emission tomography.

Tsukada H, Kreuter J, Maggos CE, Unterwald EM, Kakiuchi T, Nishiyama S, Futatsubashi M, Kreek MJ.

J Neurosci. 1996 Dec 1;16(23):7670-7.

Items per page

Supplemental Content

Write to the Help Desk